Genetic variant in Fibronectin FN1 gene reduces odds of Alzheimer's by up to 70%

This is specifically for APOEε4 carriers but it can offer insights into therapeutic targets.

A different research group has found similar findings: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11006751/